Gene · 8644
Papers2,828
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,828
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Network Pharmacology Combined with Experimental Validation Reveals the Anti-tumor Effect of Duchesnea indica against Hepatocellular Carcinoma. | J Cancer | 2023 | 37057280 | PubTator, text mining | PubMed |
| Crosstalk between omega-6 oxylipins and the enteric nervous system: Implications for gut disorders? | Front Med (Lausanne) | 2023 | 37056732 | PubTator, text mining | PubMed |
| The Impact of Obesity on the Excretion of Steroid Metabolites in Boys and Girls: A Comparison with Normal-Weight Children. | Nutrients | 2023 | 37049573 | PubTator, text mining | PubMed |
| Integrative analysis of transcriptomic landscape and urinary signature reveals prognostic biomarkers for clear cell renal cell carcinoma. | Front Oncol | 2023 | 37035174 | PubTator, text mining | PubMed |
| Decidual cells and decidualization in the carnivoran endotheliochorial placenta. | Front Cell Dev Biol | 2023 | 37009475 | PubTator, text mining | PubMed |
| Identification of candidate biomarkers and mechanisms in foam cell formation from heterogeneous cellular origins via integrated transcriptome analysis. | Ann Transl Med | 2023 | 37007574 | PubTator, text mining | PubMed |
| Bioinformatics analysis of ferroptosis-related gene AKR1C3 as a potential biomarker of asthma and its identification in BEAS-2B cells. | Comput Biol Med | 2023 | 36996663 | PubTator, text mining | PubMed |
| Anti-Ferroptotic Effects of Nrf2: Beyond the Antioxidant Response. | Mol Cells | 2023 | 36994475 | PubTator, text mining | PubMed |
| Subclinical rejection-free diagnostic after kidney transplantation using blood gene expression. | Kidney Int | 2023 | 36990211 | PubTator, text mining | PubMed |
| Perturbation of arachidonic acid and glycerolipid metabolism promoted particulate matter-induced inflammatory responses in human bronchial epithelial cells. | Ecotoxicol Environ Saf | 2023 | 36989558 | PubTator, text mining | PubMed |
| Interleukin-10 as Covid-19 biomarker targeting KSK and its analogues: Integrated network pharmacology. | PLoS One | 2023 | 36989283 | PubTator, text mining | PubMed |
| Deciphering Complex Interactions in Bioactive Lipid Signaling. | Molecules | 2023 | 36985594 | PubTator, text mining | PubMed |
| Endometriosis: Update of Pathophysiology, (Epi) Genetic and Environmental Involvement. | Biomedicines | 2023 | 36979957 | PubTator, text mining | PubMed |
| Estrogens in Adipose Tissue Physiology and Obesity-Related Dysfunction. | Biomedicines | 2023 | 36979669 | PubTator, text mining | PubMed |
| Clinical Characterization of the Expression of Insulin-Like Growth Factor Binding Protein 1 and Tumor Immunosuppression Caused by Ferroptosis of Neutrophils in Non-Small Cell Lung Cancer. | Int J Gen Med | 2023 | 36974063 | PubTator, text mining | PubMed |
| Critical Response to Article "Integrated Network Pharmacology and Experimental Validation Approach to Investigate the Mechanisms of Stigmasterol in the Treatment of Rheumatoid Arthritis" [Letter]. | Drug Des Devel Ther | 2023 | 36969706 | PubTator, text mining | PubMed |
| A novel myeloid cell marker genes related signature can indicate immune infiltration and predict prognosis of hepatocellular carcinoma: Integrated analysis of bulk and single-cell RNA sequencing. | Front Mol Biosci | 2023 | 36959981 | PubTator, text mining | PubMed |
| Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugs. | Redox Biol | 2023 | 36958250 | PubTator, text mining | PubMed |
| Polygenic Pharmacogenomic Markers as Predictors of Toxicity Phenotypes in the Treatment of Acute Lymphoblastic Leukemia: A Single-Center Study. | JCO Precis Oncol | 2023 | 36952646 | PubTator, text mining | PubMed |
| Interpretation of Steroid Biomarkers in 21-Hydroxylase Deficiency and Their Use in Disease Management. | J Clin Endocrinol Metab | 2023 | 36950738 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8644/papers?page=20